RecruitingNot applicableNCT07473635

Perineural Incobotulinumtoxin-A for Complex Regional Pain Syndrome - An Open-label Feasibility Study

Studying Complex regional pain syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Bo Biering-Soerensen
Intervention
Perineural Incobotulinumtoxin-A 200 U(drug)
Enrollment
20 enrolled
Eligibility
18 years · All sexes
Timeline
2026 – 2026

Study locations (1)

Collaborators

Merz Pharmaceuticals GmbH · The GCP unit at Copenhagen University Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07473635 on ClinicalTrials.gov

Other trials for Complex regional pain syndrome

Additional recruiting or active studies for the same condition.

See all trials for Complex regional pain syndrome →

← Back to all trials